Pallett, Laura J
Gill, Upkar S
Quaglia, Alberto
Sinclair, Linda V
Jover-Cobos, Maria
Schurich, Anna
Singh, Kasha P http://orcid.org/0000-0002-5199-9331
Thomas, Niclas
Das, Abhishek
Chen, Antony
Fusai, Giuseppe
Bertoletti, Antonio
Cantrell, Doreen A
Kennedy, Patrick T
Davies, Nathan A
Haniffa, Muzlifah
Maini, Mala K
Article History
Received: 14 January 2015
Accepted: 31 March 2015
First Online: 11 May 2015
Competing interests
: M.K.M., P.T.K. and A.B. have carried out consultancy and participated in advisory boards and educational committees for the development of novel immunotherapeutic strategies for HBV for Bristol Myers Squibb, Gilead, Immune Targeting Systems, MedImmune, Roche, Transgene.